The Congestive Heart Failure Adherence Redesign Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 320 participants.

Also called NCT01698242

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 320 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01698242
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01698242. Randomized; single masking; primary purpose prevention. Start 2011-05 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Congestive Heart Failure Adherence Redesign Trial
Acronym
CHART
Condition
Heart Failure, Congestive
Condition
Cardiovascular Diseases
Condition
Heart Diseases
Intervention (Behavioral)
Enhanced Training
Intervention (Behavioral)
Enhanced Education
Lead sponsor
Lynda Powell, PhD, MEd (class: other)
Collaborator
Cook County Health (class: other government)
Collaborator
Sinai Health System (class: other)
Collaborator
University of Illinois Chicago (class: other)

Record details

Record id
cardio:ct-nct01698242
Content hash
9b3a3f001fa8e12d5f7d660b8d9d470607c39c84963a1924a2fbb29db14af968